Can Urine Testing for Chlamydia Give False Negatives?
Yes, urine nucleic acid amplification testing (NAAT) for Chlamydia trachomatis can produce false-negative results, though modern NAATs are highly sensitive with false-negative rates typically under 3% in most clinical scenarios.
Key Mechanisms of False-Negative Results
Urinary Inhibitors
The primary cause of false-negative urine NAAT results is the presence of endogenous amplification inhibitors in urine specimens 1. These inhibitors can completely block nucleic acid amplification, leading to missed infections.
- Prevalence varies by technology: PCR (4.9%), LCR (2.6%), and TMA (7.5%) 2
- Associated urinary substances that predict inhibition include:
- Beta-human chorionic gonadotropin (pregnancy)
- Crystals
- Nitrites
- Hemoglobin 2
- Pregnant women have higher rates of PCR inhibition (9.9% vs 3.1% in non-pregnant women) 2
Low Organism Burden
False-negatives can occur when limited numbers of chlamydial organisms are present 1. This is particularly relevant in:
- Early infection stages (e.g., immediately after sexual assault) 3
- Post-treatment testing <3 weeks: Testing too early after treatment may yield false-negatives due to persistent but minimal viable organisms 1
Technical and Pre-analytical Factors
- Specimen processing losses: Some assays lose DNA during extraction, particularly the LCx assay which showed 34% false-negatives when organisms were added before processing 4
- Specimen type matters: First-void urine is superior to midstream urine, especially in women where midstream urine showed only 92.9% sensitivity compared to vaginal swabs 5
Clinical Implications and Mitigation Strategies
When False-Negatives Are Most Likely
High-risk scenarios for false-negative results:
- Testing within 2 weeks of potential exposure (insufficient organism load)
- Testing <3 weeks after completing treatment
- Using midstream rather than first-void urine
- Pregnant women (higher inhibitor rates)
- Presence of urinary tract infection or visible hematuria
Practical Solutions
To minimize false-negatives:
Specimen handling: Most inhibition can be removed by overnight storage at 4°C or -70°C followed by 1:10 dilution (removes 84-100% of inhibitors depending on assay) 2
Timing considerations:
- Wait ≥2 weeks after exposure before testing
- For test-of-cure, wait 3-4 weeks after treatment completion 1
Specimen selection: Use first-void urine rather than midstream, or preferably vaginal swabs in women 5
Repeat testing when suspicion is high: If clinical suspicion persists despite negative result, consider repeat testing or alternative specimen type
Important Caveats
The guidelines explicitly state that test-of-cure is NOT routinely recommended except in pregnant women, because the recommended regimens (azithromycin 1g single dose or doxycycline 100mg twice daily for 7 days) have 97-98% cure rates 1. The concern about false-negatives primarily applies to:
- Situations where treatment compliance is questionable
- Persistent symptoms after treatment
- Suspected reinfection
- Pregnant women (where test-of-cure IS recommended 3-4 weeks post-treatment)
Modern NAATs are the most sensitive tests available 1, with sensitivities exceeding 90% in most populations when properly collected and processed. The false-negative rate in routine clinical practice with proper specimen collection is low, making urine NAAT an excellent screening tool despite these limitations.